| P1275New |
Rofapitide tetraxetan
|
Rofapitide tetraxetan (FAP-2286) is a potent and selective FAP-binding peptidic macrocycle conjugated to the radionuclide chelator DOTA, with a mean IC50 of 2.7 nM for binding to FAP. Rofapitide tetraxetan can be radiolabeled for imaging (⁶⁸Ga, ¹¹¹In) or therapy (¹⁷⁷Lu). ¹⁷⁷Lu-FAP-2286 shows antitumor activity in FAP-expressing tumor models.
|
|
|
| E8184New |
FAPI-4
|
FAPI-4 is a potent inhibitor of fibroblast activation protein (FAP), a type II membrane-bound glycoprotein of the dipeptidyl peptidase-4 family that is expressed on cancer-associated fibroblasts, and its radiolabeled forms, such as ⁶⁸ Ga‑FAPI‑4, are highly effective agents for tumor imaging.
|
|
|
| S0842 |
SP-13786 (UAMC-1110)
|
SP-13786 (UAMC-1110)(compound 60) is a potent and selective inhibitor of fibroblast activation protein (FAP) and prolyl oligopeptidase (PREP) with IC50 of 3.2 nM and 1.8 μM, respectively.
|
|
|